Editöryal Editorial
release_qdkrqpom6rbprntjmamon7gwtu
by
At›f Görüfller, Türk Dermatologlar›, Taraf›ndan Uluslararas›, Dermatoloji Dergilerinde, Yay›nlanan At›f, Alma Oranlar›, En At›f, Alan Makaleler, Deniz Seçkin, Baflkent Üniversitesi, T›p Fakültesi, Dermatoloji Dal› (+1 others)
References
NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.| Showing 1 - 28 of 28 references (in 70ms) | ||
|---|---|---|
[b0]via fatcat |
At›f indekslerine göre Türkiye'nin bilimsel yay›n performans›n›n analizi: 1980-2003. 3. Ulusal Bilgi
M Ak , A Gülmez 2004 | |
[b1]via grobid |
Do¤an M. Araflt›rma makalelerinde yeni bir rekor: 18. s›ra. Cum- huriyet Bilim Teknoloji Dergisi, 19 Haziran 2009.
| |
[b2]via grobid |
Yurtsever E, Gülgöz S, Yedekçio¤lu ÖA, Tonta M. Sa¤l›k bilimle- ri, mühendislik ve temel bilimlerde Türkiye'nin uluslararas› at›f dizinindeki yeri: 1973-1999. Türkiye Bilimler Akademisi Yay›nlar›, Haziran 2002, Ankara.
| |
[b3]via fuzzy |
Classic and Near-Classic Articles in the Dermatologic Literature
Robert S. Stern, Kenneth A. Arndt 1999 Archives of Dermatology doi:10.1001/archderm.135.8.948 pmid:10456344 |
web.archive.org [PDF]
|
[b4]via grobid |
Uzbay IT. Bilimsel niteli¤in saptanmas›nda at›flar nas›l de¤erlen- dirilmelidir? Sa¤l›k Bilimlerinde Süreli Yay›nc›l›k 2007:129-31.
| |
[b5]via fuzzy |
An index to quantify an individual's scientific research output
J. E. Hirsch 2005 Proceedings of the National Academy of Sciences of the United States of America doi:10.1073/pnas.0507655102 pmcid:PMC1283832 pmid:16275915 |
web.archive.org [PDF]
|
[b6]via grobid |
Al U. Bilimsel yay›nlar›n de¤erlendirilmesi: h-endeksi ve Türki- ye'nin performans›. Bilgi Dünyas› 2008;9:263-85.
| |
[b7]via fuzzy |
Counting on citations: a flawed way to measure quality
Garry Walter, Karen Fisher, Sidney Bloch, Glenn Hunt 2003 Medical Journal of Australia doi:10.5694/j.1326-5377.2003.tb05196.x | |
[b8]via grobid |
Tablo 3. 1970-Nisan 2009 aras›nda yay›nlanan, 25 ve üzerinde at›f alan makaleler
| |
[b9]via grobid |
Alpsoy E, Durusoy C, Yilmaz E, et al. Interferon alfa-2a in the treatment of Behçet disease -a randomized, placebo-controlled and double- blind study. Arch Dermatol 2002; 138: 467-71. ( (A At t› ›f f s sa ay y› ›s s› ›: : 6 66 6) )
| |
[b10]via grobid |
Y›lmaz E, Alpsoy E, Baflaran E. Cimetidine therapy for warts: A placebo-controlled, double-blind study. J Am Acad Dermatol 1996; 34: 1005- 7. ( (A At t› ›f f s sa ay y› ›s s› ›: : 5 52 2) )
| |
[b11]via grobid |
Azizlerli G, Köse AA, Sar›ca R, et al. Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol 2003;42:803-6. ( (A At t› ›f f s sa ay y› ›s s› ›: : 4 44 4) )
| |
[b12]via grobid |
Aktan fi, Özmen E, fianl› B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol 2000;39:354-7. ( (A At t› ›f f s sa ay y› ›s s› ›: : 4 42 2) )
| |
[b13]via grobid |
Tüzün Y, Yaz›c› H, Pazarl› H, et al. Usefulness of the nonspecific skin hyper-reactivity (the Pathergy test) in Behçet's disease in Turkey. Acta Derm Venereol 1979;59:77-9. ( (A At t› ›f f s sa ay y› ›s s› ›: : 4 40 0) )
| |
[b14]via grobid |
Önder M, Gürer MA. The multiple faces of Behçet's disease and its aetiological factors. JEADV 2001;15:126-36. ( (A At t› ›f f s sa ay y› ›s s› ›: : 3 38 8) )
| |
[b15]via fuzzy |
Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study
O. Ermis, E. Alpsoy, L. Cetin, E. Yilmaz 2001 British Journal of Dermatology doi:10.1046/j.1365-2133.2001.04286.x pmid:11531839 | |
[b16]via fuzzy |
Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease
Umit Tursen, Aysel Gurler, Ayse Boyvat 2003 International Journal of Dermatology doi:10.1046/j.1365-4362.2003.01741.x pmid:12755969 | |
[b17]via grobid |
Alpsoy E, Y›lmaz E, Baflaran E. Interferon therapy for Behcet's disease. J Am Acad Dermatol 1994; 31:617-619. ( (A At t› ›f f s sa ay y› ›s s› ›: : 3 33 3) )
| |
[b18]via fuzzy |
Cutaneous leishmaniasis: evaluation of 3074 cases in the Çukurova region of Turkey
UZUN, USLULAR, YÜCEL, ACAR, ÖZPOYRAZ, MEMİŞOĞLU 1999 British Journal of Dermatology doi:10.1046/j.1365-2133.1999.02673.x pmid:10233236 | |
[b19]via grobid |
Erba¤c› Z, Özgöztafl› O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol 1998;37:421-5. (A At t› ›f f s sa ay y› ›s s› ›: : 3 31 1) )
| |
[b20]via grobid |
Aktan fi, Özmen E, fianl› B. Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 1998;197:230-4. ( (A At t› ›f f s sa ay y› ›s s› ›: : 3 31 1) )
| |
[b21]via grobid |
Utafl S, Özbakir O, Turasan A, Utafl C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 1999;40:433-5. ( (A At t› ›f f s sa ay y› ›s s› ›: : 2 29 9) )
| |
[b22]via grobid |
Yalçin B, Sahin S, Bükülmez G, et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. J Am Acad Dermatol 2001;44:634-7. ( (A At t› ›f f s sa ay y› ›s s› ›: : 2 29 9) )
| |
[b23]via grobid |
Alpsoy E, Er H, Durusoy Ç, et al. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease-A ran- domized, placebo-controlled double-blind study. Arch Dermatol 1999;135:529-32. ( (A At t› ›f f s sa ay y› ›s s› ›: : 2 27 7) )
| |
[b24]via grobid |
Azizlerli G, Sar›ca R, Köse A, et al. Interferon alfa-2a in the treatment of Behçet's disease. Dermatology 1996;192:239-41. ( (A At t› ›f f s sa ay y› ›s s› ›: : 2 27 7) )
| |
[b25]via fatcat |
Cutaneous leishmaniasis in fianl›urfa: epidemiologic and clinical features of the last four years (19972000)
M Gürel , M Ulukanl›gil , H Özbilge 2002 volume:41 | |
[b26]via grobid |
Int J Dermatol 2002;41:32-7. ( (A At t› ›f f s sa ay y› ›s s› ›: : 2 27 7) )
| |
[b27]via grobid |
Erdo¤an FG, Yurtsever P, Aksoy D, et al. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998;134:884-5. ( (A At t› ›f f s sa ay y› ›s s› ›: : 2 26 6) )
| |